Olfr736 Inhibitors
Olfr735 is an olfactory receptor in mice, belonging to the large family of G-protein-coupled receptors (GPCRs). These receptors play a crucial role in detecting odorant molecules and initiating neuronal responses that lead to the perception of smell. The unique structure of olfactory receptors, which includes seven transmembrane domains, is shared with many neurotransmitter and hormone receptors. This structural similarity underlies a common mechanism of action: the recognition of specific ligands (in this case, odorant molecules) and the subsequent activation of G proteins, leading to a cascade of intracellular signaling events. The process of inhibiting olfactory receptors like Olfr735 is not straightforward and involves a nuanced understanding of the interconnected pathways in which these receptors function. GPCRs, including olfactory receptors, often utilize secondary messengers like cyclic AMP (cAMP) and involve complex interactions with various neurotransmitter systems. Therefore, inhibition can occur through multiple indirect routes. For example, compounds that modulate the levels of cAMP - either by influencing its production or degradation - can indirectly impact the signaling of olfactory receptors. This is because the activation of GPCRs often leads to changes in cAMP levels, which in turn regulate various cellular processes.
Another indirect route of inhibition involves the modulation of different neurotransmitter systems that interact with or influence GPCR signaling. For instance, antagonists of adrenergic, dopaminergic, or serotonergic receptors can alter the neurochemical environment and thus indirectly affect the functioning of olfactory receptors. These changes might occur through alterations in neurotransmitter levels, receptor availability, or the balance of excitatory and inhibitory signals in neuronal networks. In summary, while there are no known direct inhibitors of Olfr735, understanding the broader signaling pathways and molecular interactions in which this receptor participates opens possibilities for indirect inhibition. This involves considering a range of compounds that can influence cAMP dynamics or modulate various neurotransmitter systems, thereby indirectly impacting the signaling of Olfr735 and potentially altering olfactory perception.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a non-selective beta-adrenergic receptor antagonist. By blocking these receptors, it can reduce the levels of cyclic AMP (cAMP), a secondary messenger in GPCR signaling. Lower cAMP levels might indirectly reduce Olfr735 signaling, as cAMP is often involved in olfactory receptor signaling pathways. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
Carvedilol is a non-selective beta-blocker with alpha-1 blocking activity. It lowers cAMP levels by inhibiting adrenergic receptors, which can indirectly affect GPCR-mediated signaling pathways including those involving olfactory receptors like Olfr735. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Yohimbine is an alpha-2 adrenergic receptor antagonist. By inhibiting these receptors, it can increase neurotransmitter release, potentially altering GPCR signaling cascades, including those related to Olfr735, by modulating the cellular context of the receptor's activation. | ||||||
Ketanserin | 74050-98-9 | sc-279249 | 1 g | $700.00 | ||
Ketanserin is a selective 5-HT2A serotonin receptor antagonist. It modifies serotonin signaling, potentially affecting GPCR-mediated pathways, including those involving olfactory receptors, due to the widespread role of serotonin in modulating neuronal signaling. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A sc-200402B sc-200402C | 50 mg 500 mg 5 g 10 g | $69.00 $364.00 $2500.00 $4100.00 | 11 | |
Clozapine is an atypical antipsychotic that acts as a serotonin-dopamine antagonist. This drug affects multiple neurotransmitter systems and could indirectly impact GPCR signaling, including olfactory receptors, by altering neurotransmitter levels and receptor availability. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol is a dopamine antagonist primarily used as an antipsychotic. It influences dopamine pathways, which could indirectly affect GPCR signaling including olfactory receptors by modulating dopaminergic activity. | ||||||
Risperidone | 106266-06-2 | sc-204881 sc-204881A sc-204881B sc-204881C | 10 mg 50 mg 1 g 5 g | $174.00 $719.00 $1020.00 $2040.00 | 1 | |
Risperidone is an antipsychotic drug that acts as a dopamine and serotonin antagonist. It affects multiple neurotransmitter systems, potentially impacting GPCR signaling pathways, including those of olfactory receptors, by altering the neurochemical environment. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $82.00 $333.00 | 1 | |
Ondansetron is a serotonin 5-HT3 receptor antagonist. It modulates serotonin signaling, potentially affecting GPCR-mediated pathways, including olfactory receptor pathways, by altering the serotonergic system. | ||||||
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $79.00 $416.00 | 1 | |
Atenolol is a selective beta1-adrenergic receptor antagonist. By specifically targeting beta1 receptors, it could indirectly influence GPCR signaling pathways, including olfactory receptors, by modulating adrenergic activity and cAMP levels. | ||||||
Metoprolol Tartrate | 56392-17-7 | sc-205751 sc-205751A | 5 g 25 g | $107.00 $243.00 | 3 | |
Metoprolol is a beta1-adrenergic receptor blocker. Its selective action on beta1 receptors could indirectly affect GPCR signaling, including Olfr735, by altering cAMP levels and adrenergic signaling dynamic | ||||||